Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$18.06 - $25.3 $1,896 - $2,656
-105 Reduced 0.85%
12,244 $271,000
Q4 2023

Feb 13, 2024

SELL
$12.19 - $22.43 $609 - $1,121
-50 Reduced 0.4%
12,349 $266,000
Q3 2023

Nov 13, 2023

BUY
$13.28 - $20.3 $5,856 - $8,952
441 Added 3.69%
12,399 $209,000
Q2 2023

Aug 04, 2023

BUY
$11.66 - $26.0 $1,352 - $3,016
116 Added 0.98%
11,958 $164,000
Q1 2023

May 12, 2023

BUY
$19.47 - $28.49 $4,575 - $6,695
235 Added 2.02%
11,842 $269,000
Q4 2022

Feb 10, 2023

SELL
$18.08 - $30.0 $759 - $1,260
-42 Reduced 0.36%
11,607 $273,000
Q3 2022

Nov 14, 2022

BUY
$22.51 - $34.32 $11,682 - $17,812
519 Added 4.66%
11,649 $304,000
Q2 2022

Aug 12, 2022

BUY
$16.0 - $45.99 $8,832 - $25,386
552 Added 5.22%
11,130 $244,000
Q1 2022

May 13, 2022

SELL
$33.17 - $46.98 $24,711 - $35,000
-745 Reduced 6.58%
10,578 $475,000
Q4 2021

Feb 11, 2022

SELL
$39.06 - $67.58 $13,241 - $22,909
-339 Reduced 2.91%
11,323 $485,000
Q3 2021

Nov 12, 2021

SELL
$60.13 - $77.6 $16,595 - $21,417
-276 Reduced 2.31%
11,662 $776,000
Q2 2021

Aug 13, 2021

BUY
$50.07 - $76.78 $172,691 - $264,814
3,449 Added 40.63%
11,938 $875,000
Q1 2021

May 07, 2021

BUY
$58.92 - $97.33 $93,800 - $154,949
1,592 Added 23.08%
8,489 $581,000
Q4 2020

Feb 12, 2021

SELL
$43.6 - $73.05 $5,101 - $8,546
-117 Reduced 1.67%
6,897 $463,000
Q3 2020

Nov 04, 2020

BUY
$38.47 - $52.03 $28,660 - $38,762
745 Added 11.88%
7,014 $361,000
Q2 2020

Aug 12, 2020

BUY
$27.28 - $43.01 $17,977 - $28,343
659 Added 11.75%
6,269 $236,000
Q1 2020

May 04, 2020

BUY
$23.08 - $35.53 $74,733 - $115,046
3,238 Added 136.51%
5,610 $167,000
Q4 2019

Feb 05, 2020

BUY
$15.74 - $35.04 $629 - $1,401
40 Added 1.72%
2,372 $82,000
Q3 2019

Nov 08, 2019

BUY
$18.09 - $27.92 $42,185 - $65,109
2,332 New
2,332 $42,000

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $739M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.